Protein drugs feature significant advantages over small molecule therapeutics, including low toxicity, high specificity, and development speed. However, the quality control requirements are ...

Analyzing charge variants of biopharmaceuticals is a critical component of product development and quality control. Charge variants commonly occur as a result of both chemical and post-translational ...